Aspiriant LLC’s iShares Emerging Markets Dividend ETF DVYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,958
Closed -$424K 267
2022
Q2
$424K Hold
15,958
0.02% 175
2022
Q1
$522K Hold
15,958
0.03% 172
2021
Q4
$615K Buy
15,958
+1,267
+9% +$49K 0.03% 167
2021
Q3
$572K Buy
14,691
+6,300
+75% +$244K 0.03% 151
2021
Q2
$326K Buy
8,391
+104
+1% +$4.15K 0.02% 192
2021
Q1
$324K Hold
8,287
0.02% 173
2020
Q4
$309K Buy
8,287
+127
+2% +$4.25K 0.02% 171
2020
Q3
$246K Hold
8,160
0.02% 196
2020
Q2
$256K Buy
+8,160
New +$253K 0.02% 164
2019
Q3
Sell
-5,249
Closed -$214K 217
2019
Q2
$214K Hold
5,249
0.02% 213
2019
Q1
$212K Buy
+5,249
New +$212K 0.02% 215
2017
Q3
Sell
-9,191
Closed -$369K 207
2017
Q2
$369K Sell
9,191
-222
-2% -$8.93K 0.03% 159
2017
Q1
$375K Buy
+9,413
New +$360K 0.03% 163

Other funds holding DVYE

Aspiriant LLC's DVYE Position: Q3 2022 in Review

Aspiriant LLC sold out of iShares Emerging Markets Dividend ETF (DVYE) in Q3 2022, closing a stake of 15,958 shares — an estimated $424K sold.

Aspiriant LLC first reported a position in DVYE in Q1 2017 and held it in 13 quarters. The position peaked at $615K in Q4 2021. 112 funds tracked by Wall St. Rank hold DVYE as of Q3 2022.

  • Aspiriant LLC reported no remaining iShares Emerging Markets Dividend ETF position as of Q3 2022 after selling out during the quarter.
  • Aspiriant LLC sold 15,958 iShares Emerging Markets Dividend ETF shares in Q3 2022, an estimated $424K.
  • Aspiriant LLC first reported a position in iShares Emerging Markets Dividend ETF in Q1 2017 and held it in 13 quarters.
  • Aspiriant LLC's iShares Emerging Markets Dividend ETF position peaked at $615K in Q4 2021.
  • 112 funds tracked by Wall St. Rank held iShares Emerging Markets Dividend ETF as of Q3 2022.

Based on Aspiriant LLC's 13F filing for Q3 2022, filed 28 Oct 2022.